JSCapital
Overview
JSCapital is an Israeli investment and technology transfer platform that provides international investors, corporations, and government agencies access to the Israeli startup market. The firm focuses on investments in sectors including Artificial Intelligence, FinTech, Quantum Computing, Digital Healthcare, Semiconductors, and Cyber Security.
Portfolio Companies
10
Website
jscapital.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Commonwealth Fusion Systems | Dec 2021 | Series B | - |
| Plenty | Jan 2022 | Series E | Lead |
| Element Biosciences | Jan 2020 | Series B | Lead |
| Merlin Labs | Jul 2022 | Series B | Co-investor |
| MyGate | Oct 2019 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is JSCapital based?
JSCapital is headquartered in Tel Aviv District.
When was JSCapital founded?
Founding year information for JSCapital is not publicly available.
How many portfolio companies does JSCapital have?
JSCapital has 10 portfolio companies in Caplight's dataset.
What are some companies in JSCapital's portfolio?
Portfolio companies visible on Caplight include Commonwealth Fusion Systems, Plenty, Element Biosciences, Merlin Labs, MyGate.
What was JSCapital's most recent investment shown here?
JSCapital's most recent investment in this portfolio sample was in Merlin Labs in 2022.
What sectors does JSCapital focus on?
JSCapital focuses on Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Energy & Sustainability, FinTech, FinTech, Consumer & Commerce, Mobility, Transportation & Logistics, Real Estate & PropTech, Frontier & Industrial Tech, Frontier & Industrial Tech, Enterprise Software, Mobility, Transportation & Logistics, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce.
What company stages does JSCapital focus on?
JSCapital typically invests at the Mid stage.